搜索结果101-110 的 7566 / 서정리오피▶ YEOTOP4.COM ◀ 여탑◈긍정적인◈서정리오피☼서정리립카페ぷ서정리OP⊙서정리키스방☳서정리스파✑서정리출장

  1. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  2. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ethnic populations seeking care at Mayo Clinic ...

  3. 神经科- 临床试验- 妙佑医疗国际

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

  4. 神经科- 临床试验- 妙佑医疗国际

    Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ...

  5. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  6. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to develop a prospective status epilepticus registry among twelve tertiary care pediatric hospitals in the United States focused on ...

  7. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may ...

  8. 神经科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this research is to develop stem cells from cells within patients' skin in order to better understand peripheral neuropathy and ...

  9. 神经科- 临床试验- 妙佑医疗国际

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may ...

  10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to confirm detection of the H3K27M mutation in patient biofluids (CSF, blood, urine, saliva) and uncover the molecular histone ( ...